Cargando…
The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)
BACKGROUND: Targeting leptin could represent a rational strategy to treat amyotrophic lateral sclerosis (ALS), as previously clinical studies have shown its levels to be associated with a lower risk of ALS disease. However, very little is known about the potential influence of leptin in altering dis...
Autores principales: | Ferrer‐Donato, Agueda, Contreras, Ana, Fernandez, Paloma, Fernandez‐Martos, Carmen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785645/ https://www.ncbi.nlm.nih.gov/pubmed/34935299 http://dx.doi.org/10.1002/brb3.2465 |
Ejemplares similares
-
Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)
por: Ferrer-Donato, Agueda, et al.
Publicado: (2021) -
Design of
Mesoporous Silica Nanoparticles for the
Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic
Cocktail Based on Leptin and Pioglitazone
por: Díaz-García, Diana, et al.
Publicado: (2022) -
Methodology Aspects of Colony Maintain for a Murine Model of Amyotrophic Lateral Sclerosis (ALS) TDP-43 Proteinopathy
por: Álvaro-Alonso, César, et al.
Publicado: (2020) -
Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
por: Sebastião, Ana M., et al.
Publicado: (2018) -
Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis
por: Teruel-Peña, Bárbara, et al.
Publicado: (2023)